Inducible protein-10, a potential driver of neurally controlled interleukin-10 and morbidity in human blunt trauma

Critical Care Medicine

Volumn 42, Issue 6, 2014, Pages 1487-1497

  Zaaqoq, Akram M ^a   Namas, Rami ^b,c   Almahmoud, Khalid ^b   Azhar, Nabil ^b   Mi, Qi ^c   Zamora, Ruben ^b,c   Brienza, David M ^c,d   Billiar, Timothy R ^b,c   Vodovotz, Yoram ^b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d University of Pittsburgh   (United States)

Author keywords

Chemokines; inflammation; nervous system; neurogenic inflammation; spinal cord injuries; trauma

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; BLOOD LEVEL; BLUNT TRAUMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; INJURY SEVERITY; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MECHANICAL VENTILATOR; MORBIDITY; PRIORITY JOURNAL; SPINAL CORD INJURY;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BIOLOGICAL MARKERS; CHEMOKINE CXCL10; CHEMOKINES; COHORT STUDIES; COMPUTER SIMULATION; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INJURY SEVERITY SCORE; INTERLEUKIN-10; LENGTH OF STAY; MALE; MIDDLE AGED; NITROGEN OXIDES; RETROSPECTIVE STUDIES; SPINAL CORD INJURIES; WOUNDS, NONPENETRATING;

EID: 84901491102     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000248     Document Type: Article

References (42)

1. Cuschieri J, Johnson JL, Sperry J, et al; Inflammation and Host Response to Injury, Large Scale Collaborative Research Program: Benchmarking outcomes in the critically injured trauma patient and the effect of imp lementing standard operating procedures. Ann Surg 2012; 255:993-999
2. Thuret S, Moon LD, Gage FH: Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 2006; 7:628-643
3. Burt BM, Afifi HY, Wantz GE, et al: Traumatic lumbar hernia: Report of cases and comprehensive review of the literature. J Trauma 2004; 57:1361-1370
4. Cripps RA, Lee BB, Wing P, et al: A global map for traumatic spinal cord injury epidemiology: Towards a living data repository for injury prevention. Spinal Cord 2011; 49:493-501
5. Gris D, Hamilton EF, Weaver LC: The systemic inflammatory response after spinal cord injury damages lungs and kidneys. Exp Neurol 2008; 211:259-270
6. Fleming JC, Norenberg MD, Ramsay DA, et al: The cellular inflammatory response in human spinal cords after injury. Brain 2006; 129:3249-3269
7. Auner B, Geiger EV, Henrich D, et al: Circulating leukotriene B4 identifies respiratory complications after trauma. Mediators Inflamm 2012; 2012:536156
8. An G, Namas RA, Vodovotz Y: Sepsis: From pattern to mechanism and back. Crit Rev Biomed Eng 2012; 40:341-351
9. An G, Nieman G, Vodovotz Y: Computational and systems biology in trauma and sepsis: Current state and future perspectives. Int J Burns Trauma 2012; 2:1-10
10. Vodovotz Y, Csete M, Bartels J, et al: Translational systems biology of inflammation. PLoS Comput Biol 2008; 4:e1000014
11. Vodovotz Y, Billiar TR: In silico modeling: Methods and applications to trauma and sepsis. Crit Care Med 2013; 41:2008-2014
12. Cohen MJ, Grossman AD, Morabito D, et al: Identification of complex metabolic states in critically injured patients using bi oinformatic cluster analysis. Crit Care 2010; 14:R10
13. Xiao W, Mindrinos MN, Seok J, et al; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program: A genomic storm in critically injured humans. J Exp Med 2011; 208: 2581-2590
14. Vincent JL, de Souza Barros D, Cianferoni S: Diagnosis, management and prevention of ventilator-associated pneumonia: An update. Drugs 2010; 70:1927 -1944
15. Grzegorczyk M,Husmeier D, Improvements in the reconstruction of time-varying gene regulatory networks: Dynamic programming and regularization by information sharing among gene s, Bioinformatics,2011,27, 693-699.
16. Azhar N, Ziraldo C, Barclay D, et al; Pediatric Acute Liver Failure Study Group: Analysis of serum inflammatory mediators identifies unique dynamic networ ks associated with death and spontaneous survival in pediatric acute liver failure. PLoS One 2013; 8:e78202
17. Langmead CJ: Generalized Queries and Bayesian Statistical Model Checking in Dynamic Bayesian Networ ks: Application to Personalized Medicine. Pittsburgh, PA, School of Computer Science, Carnegie Mellon University, 2009
18. Zou KH, O? Malley AJ, Mauri L: Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models. Circulation 2007; 115:654-657
19. El Masry WS, Tsubo M, Katoh S, et al: Validation of the American Spinal Injury Association (ASIA) motor score and the Nat ional Acute Spinal Cord Injury Study (NASCIS) motor score. Spine (Phila Pa 1976) 1996; 21:614-619
20. Tschoeke SK, Ertel W: Immunoparalysis after multiple trauma. Injury 2007; 38:1346-1357
21. Devivo MJ: Epidemiology of traumatic spinal cord injury: Trends and future implications. Spinal Cord 2012; 50:365-372
22. Lucin KM, Sanders VM, Jones TB, et al: Impaired antibody synthesis after spinal cord injury is level dependent and is due to sympathetic nervous system dysregulation. Exp Neurol 2007; 207:75-84
23. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
24. Winslow C, Rozovsky J: Effect of spinal cord injury on the respiratory system. Am J Phys Med Rehabil 2003; 82:803-814
25. Ziraldo C, Vodovotz Y, Namas RA, et al: Central role for MCP-1/CCL2 in injury-induced inflammation revealed by in vitro, in silico, and clinic al studies. PLoS One 2013; 8:e79804
26. Eskandari F, Webster JI, Sternberg EM: Neural immune pathways and their connection to inflammatory diseases. Arthritis Res Ther 2003; 5:251-265
27. Turnbull AV, Rivier CL: Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999; 79:1-71
28. McTigue DM: Potential therapeutic targets for PPARgamma after spinal cord injury. PPAR Res 2008; 2008:517162
29. Beattie MS: Inflammation and apoptosis: Linked therapeutic targets in spinal cord injury. Trends Mol Med 2004; 10:580-583
30. Nash MS: Known and plausible modulators of depressed immune functions following spinal cord injuries. J Spinal Cord Med 2000; 23:111-120
31. Deng ZL, Sharff KA, Tang N, et al: Regulation of osteogenic differentiation during skeletal development. Front Biosci 2008; 13:2001-2021
32. Genovese T, Esposito E, Mazzon E, et al: Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice. J Neurochem 2009; 108:1360-1372
33. Narumi S, Kaburaki T, Yoneyama H, et al: Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol 2002; 32:1784-1791
34. Babcock AA, Kuziel WA, Rivest S, et al: Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003; 23:7922-7930
35. Gonzalez R, Glaser J, Liu MT, et al: Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury. Exp Neurol 2003; 184:456-463
36. C haitanya GV, Kolli M, Babu PP: Granzyme-b mediated cell death in the spinal cord-injured rat model. Neuropathology 2009; 29:270-279
37. Jones TB, Hart RP, Popovich PG: Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury. J Neurosci 2005; 25:6576-6583
38. Dorsey R, Kundu N, Yang Q, et al: Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. Cancer Res 2002; 62:2606-2610
39. Imakawa K, Nagaoka K, Nojima H, et al: Changes in immune cell distribution and IL-1 0 production are regulated through endometrial IP-10 expression in the goat uterus. Am J Reprod Immunol 2005; 53:54-64
40. Platzer C, Dö cke W, Volk H, et al: Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 2000; 105:31-38
41. Brenner S, Prö sch S, Schenke-Layland K, et al: cAM P-induced Interleukin-10 promoter activation depends on CCAAT/enhancerbinding protein expression and monocytic differentiation. J Biol Chem 2003; 278:5597-5604
42. Vanhems P, Bé net T, Voirin N, et al; Study Group: Early-onset ventilator-associated pneumonia incidence in intensive care units: A surveillance-based study. BMC Infect Dis 2011; 11:236